TIAA CREF Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$6.75M Buy
106,317
+11,889
+13% +$625K ﹤0.01% 1265
2018
Q4
$3.58M Sell
94,428
-4,141
-4% -$146K ﹤0.01% 1582
2018
Q3
$4.22M Buy
98,569
+697
+0.7% +$24.3K ﹤0.01% 1681
2018
Q2
$2.15M Buy
+97,872
New +$1.2M ﹤0.01% 2134
2017
Q1
Sell
-5,888
Closed -$127K 3091
2016
Q4
$127K Sell
5,888
-1,990
-25% -$76.6K ﹤0.01% 3071
2016
Q3
$603 Hold
7,878
﹤0.01% 2777
2016
Q2
$594K Buy
7,878
+2,134
+37% +$172K ﹤0.01% 2787
2016
Q1
$500K Sell
5,744
-444
-7% -$38.8K ﹤0.01% 2785
2015
Q4
$731K Hold
6,188
﹤0.01% 2759
2015
Q3
$545K Buy
6,188
+1,661
+37% +$193K ﹤0.01% 2861
2015
Q2
$491K Buy
4,527
+1,273
+39% +$158K ﹤0.01% 2964
2015
Q1
$411K Buy
3,254
+282
+9% +$36.7K ﹤0.01% 2968
2014
Q4
$377K Sell
2,972
-224
-7% -$31.1K ﹤0.01% 3026
2014
Q3
$429K Hold
3,196
﹤0.01% 3008
2014
Q2
$520K Buy
3,196
+761
+31% +$129K ﹤0.01% 3000
2014
Q1
$538K Hold
2,435
﹤0.01% 2917
2013
Q4
$628K Buy
+2,435
New +$557K ﹤0.01% 2895

Other funds holding TNDM

TIAA CREF Investment Management's TNDM Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Tandem Diabetes Care (TNDM) stake by 13% in Q1 2019, buying an estimated $625K and bringing the position to 106,317 shares worth $6.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1265.

TIAA CREF Investment Management first reported a position in TNDM in Q4 2013 and has held it in 17 quarters since. 265 funds tracked by Wall St. Rank hold TNDM as of Q1 2019.

  • TIAA CREF Investment Management held 106,317 shares of Tandem Diabetes Care worth $6.75M as of Q1 2019.
  • TIAA CREF Investment Management bought 11,889 Tandem Diabetes Care shares in Q1 2019, an estimated $625K.
  • Tandem Diabetes Care made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1265 holding.
  • TIAA CREF Investment Management first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 17 quarters since.
  • 265 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.